Photo: Courtesy of Teva
US-based biopharmaceutical company Arena Pharmaceuticals and Eisai, a drugs company based in Japan, have filed a complaint against Teva for patent infringement over a weight-loss generic drug.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Teva, ANDA, patent, FDA, Arena, Eisai, weight management, generic, patent infringement,
